PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New approach prevents thrombosis without increasing the risk of bleeding

2014-02-06
(Press-News.org) Contact information: Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet
New approach prevents thrombosis without increasing the risk of bleeding In collaboration with an international team, researchers at Karolinska Institutet in Sweden have developed an antibody, 3F7, which blocks a protein that is active in the coagulation system factor XII. Inhibition of factor XII makes it possible to prevent thrombosis in blood vessels without increasing the risk of bleeding in clinical settings.

Thrombosis is caused by blood clotting; clots can block blood flow in one or more blood vessels and so cause thrombotic diseases such as stroke, myocardial infarction or pulmonary embolism. Today, thrombosis is prevented or treated by means of anticoagulants. There is a broad variety of anticoagulant drugs, such as warfarin (a vitamin K inhibitor), the novel oral anticoagulants (dabigatran or rivaroxaban) and drugs of the heparin group. All of these agents target different components of the blood coagulation system to prevent blood from clotting and thus to interfere with thrombosis. However, all these drugs also entail an increased risk of bleeding in patients that partially offsets their beneficial effects.

The blocking of coagulation factor XII (F XII) functions differently compared to traditional anticoagulants. It has been known for long time that humans that are deficient in FXII do not bleed excessively and because of that FXII was believed to have no function for blood coagulation in patients. In 2005, Thomas Renné and his research team discovered that mice lacking F XII could have neither a stroke nor pulmonary embolism, even though they had normal bleeding patterns.

"Since then, our goal has been to find an effective way to block F XII. Now, we have developed an antibody that blocks F XII in human blood, mice and rabbits", says Thomas Renné. "This provides protection against thrombosis without increasing the risk of bleeding."

Together with the doctoral student Magnus Larsson, the researchers developed and tested the antibody, called 3F7, in rabbits during an ECMO treatment. ECMO is an advanced heart-lung machine used in life-threatening conditions especially in infants. Contact with the plastic tubing causes the blood to clot, so patients are routinely administered with anticoagulants (heparin). However due to the heparin anticoagulation patients bleed excessively and a substantial number even dies from these bleedings.

In the study, thrombosis in rabbits on ECMO receiving 3F7 decreased was as low as rabbits receiving heparin, but the risk of bleeding with 3F7 was minimal, whereas heparin-treatment led to bleeding.

"Blocking F XII appears to be an effective strategy against thrombus formation, and we have shown this in experiments on rabbits in a clinically relevant context", says Thomas Renné. "There is a great need for a treatment that reduces the clot risk in emergency situations, such as during ECMO treatment and many others such as cardiovascular surgery. We plan to test the antibody in a phase I study. It is possible that the antibody also blocks inflammation mediated by F XII, an interesting area for future studies."

### The study was funded by Swedish Heart-Lung Foundation, Stockholm County Council (ALF), the Swedish Cancer Society, HRH Crown Princess Lovisa's Association for Child Medical Care, the Swedish Research Council, the German Research Society and the European Research Council. Several of those involved in the study are employees of the pharmaceutical company CSL Behring, which has consequently contributed to the study's inception.

Publication: 'A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk', Magnus Larsson, Veronika Rayzman, Msarc W. Nolte, Katrin F. Nickel, Jenny Björkqvist, Anne Jämsä, Matthew P. Hardy, Marion Fries, Stefan Schmidbauer, Patricia Hedenqvist, Michael Broomé, Ingo Pragst, Gerhard Dickneite, Michael J. Wilson, Andrew D. Nash, Con Panousis and Thomas Renné, Science Translational Medicine, 5 February 2014 Vol 6 Issue 222 222ra17.

Contact the Press Office and download images: http://ki.se/pressroom

Website of the journal: http://stm.sciencemag.org/

Karolinska Institutet - a medical university: http://ki.se/english


ELSE PRESS RELEASES FROM THIS DATE:

Some receive unnecessary prioritization for liver transplantation, says Penn Medicine study

2014-02-06
(PHILADELPHIA) – Patients waiting for liver transplants ...

New analysis of endometriosis could help diagnoses, treatments

2014-02-06
CAMBRIDGE, MA -- Endometriosis, the invasive displacement of uterine tissue into surrounding organs, affects at least 10 percent of women. The disease, which is often misdiagnosed, can cause ...

Female mice prefer unfamiliar male songs

2014-02-06
Female mice prefer songs of mice that are different from their parents when selecting a mate, according to a study published February 5, 2014 in PLOS ONE by Akari Asaba from the Azabu University, ...

Mass extinction may not cause all organisms to 'shrink'

2014-02-06
The sizes of organisms following mass extinction events may vary more than previously thought, which may be inconsistent with the predictions of the so-called ...

Tree roots in the mountains 'acted like a thermostat' for millions of years

2014-02-06
For the first time, scientists have discovered how tree roots in the mountains may play an important role in controlling long-term global temperatures. Researchers from Oxford ...

New stem cell research removes reliance on human and animal cells

2014-02-06
A new study, published today in the journal Applied Materials & Interfaces, has found a new method for growing human embryonic stem cells, that doesn't rely on supporting human or animal cells. Traditionally, ...

Study shows yogurt consumption reduces the risk of type 2 diabetes

2014-02-06
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that higher consumption of yoghurt, compared with no consumption, can reduce ...

Scientists create potential vaccine ingredient for childhood respiratory disease

2014-02-06
LA JOLLA, CA—February 5, 2014—Scientists at The ...

Social media analysis shows the Garment District still rules New York fashion

2014-02-06
A new study shows New York fashion designers don't just flock ...

Quarks in the looking glass

2014-02-06
From matching wings on butterflies to the repeating six-point pattern of snowflakes, symmetries echo through nature, even down to the smallest building blocks of matter. Since the discovery of quarks, the building ...

LAST 30 PRESS RELEASES:

It takes a village: Chimpanzee babies do better when their moms have social connections

From lab to market: how renewable polymers could transform medicine

Striking increase in obesity observed among youth between 2011 and 2023

No evidence that medications trigger microscopic colitis in older adults

NYUAD researchers find link between brain growth and mental health disorders

Aging-related inflammation is not universal across human populations, new study finds

University of Oregon to create national children’s mental health center with $11 million federal grant

Rare achievement: UTA undergrad publishes research

Fact or fiction? The ADHD info dilemma

Genetic ancestry linked to risk of severe dengue

Genomes reveal the Norwegian lemming as one of the youngest mammal species

Early birds get the burn: Monash study finds early bedtimes associated with more physical activity

Groundbreaking analysis provides day-by-day insight into prehistoric plankton’s capacity for change

Southern Ocean saltier, hotter and losing ice fast as decades-long trend unexpectedly reverses

Human fishing reshaped Caribbean reef food webs, 7000-year old exposed fossilized reefs reveal

Killer whales, kind gestures: Orcas offer food to humans in the wild

Hurricane ecology research reveals critical vulnerabilities of coastal ecosystems

Montana State geologist’s Antarctic research focuses on accumulations of rare earth elements

Groundbreaking cancer therapy clinical trial with US Department of Energy’s accelerator-produced actinium-225 set to begin this summer

Tens of thousands of heart attacks and strokes could be avoided each year if cholesterol-lowering drugs were used according to guidelines

Leading cancer and metabolic disease expert Michael Karin joins Sanford Burnham Prebys

Low-intensity brain stimulation may restore neuron health in Alzheimer's disease

Four-day school week may not be best for students, review finds

Using music to explore the dynamics of emotions

How the brain supports social processing as people age

Túngara frog tadpoles that grew up in the city developed faster but ended up being smaller

Where there’s fire, there’s smoke

UCLA researchers uncover key mechanism of brain repair in vascular dementia, revealing promising therapeutic target

Why Human empathy still matters in the age of AI

COVID-19 and cognitive change in a community-based cohort

[Press-News.org] New approach prevents thrombosis without increasing the risk of bleeding